Literature DB >> 2346497

Interleukin-6 stimulates c-myc expression and proliferation of cultured vascular smooth muscle cells.

T Nabata1, S Morimoto, E Koh, T Shiraishi, T Ogihara.   

Abstract

The effects of interleukin-6 (IL-6), a cytokine recently found to be secreted by monocytes and macrophages, on c-myc expression and proliferation of cultured vascular smooth muscle cells (VSMC) were investigated. Treatment with IL-6 caused rapid increase in the c-myc mRNA level of VSMC. It also stimulated DNA synthesis and proliferation of the cells significantly and dose-dependently at concentrations of more than 10 U/ml. These results suggest that IL-6 may be important in the proliferation of VSMC, which is a key event in the development of arteriosclerosis, as a factor mediating immune cell-VSMC interaction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2346497

Source DB:  PubMed          Journal:  Biochem Int        ISSN: 0158-5231


  21 in total

1.  Role of ACE I/D gene polymorphisms on the effect of ramipril in inflammatory response and myocardial injury in patients undergoing coronary artery bypass grafts.

Authors:  Meral Urhan Küçük; Nehir Sucu; Seyhan Şahan Firat; Barlas Naim Aytaçoğlu; Özden Vezir; Caner Bozali; Necmiye Canacankatan; Seval Kul; Bahar Tunçtan
Journal:  Eur J Clin Pharmacol       Date:  2014-09-27       Impact factor: 2.953

2.  Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release.

Authors:  D J Brull; J Sanders; A Rumley; G D Lowe; S E Humphries; H E Montgomery
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

3.  Cell proliferation and interleukin-6-type cytokine signaling are implicated by gene expression responses in early optic nerve head injury in rat glaucoma.

Authors:  Elaine C Johnson; Thomas A Doser; William O Cepurna; Jennifer A Dyck; Lijun Jia; Ying Guo; Wendi S Lambert; John C Morrison
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-25       Impact factor: 4.799

4.  CBP knockdown inhibits angiotensin II-induced vascular smooth muscle cells proliferation through downregulating NF-kB transcriptional activity.

Authors:  Jian Yang; Hong Jiang; Si-si Chen; Jing Chen; Sheng-kai Xu; Wan-qiang Li; Ji-chun Wang
Journal:  Mol Cell Biochem       Date:  2010-02-16       Impact factor: 3.396

5.  Interleukin-6 and interleukin-6 receptor gene expression in pituitary tumors.

Authors:  A R Rezai; A Rezai; O Martínez-Maza; M Vander-Meyden; M H Weiss
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

6.  IL-6 gene polymorphisms and CAD risk: a meta-analysis.

Authors:  Yuan Yang; Fan Zhang; Laura Skrip; Han Lei; Yang Wang; Dayi Hu; Rongjing Ding
Journal:  Mol Biol Rep       Date:  2012-12-16       Impact factor: 2.316

Review 7.  Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.

Authors:  Giovanni Anfossi; Isabella Russo; Gabriella Doronzo; Alice Pomero; Mariella Trovati
Journal:  Mediators Inflamm       Date:  2010-06-28       Impact factor: 4.711

8.  Platelet factor 4 mediates vascular smooth muscle cell injury responses.

Authors:  Guanfang Shi; David J Field; Xiaochun Long; Deanne Mickelsen; Kyung-ae Ko; Sara Ture; Vyacheslav A Korshunov; Joseph M Miano; Craig N Morrell
Journal:  Blood       Date:  2013-04-08       Impact factor: 22.113

9.  IL-6 induced STAT3 signalling is associated with the proliferation of human muscle satellite cells following acute muscle damage.

Authors:  Kyle G Toth; Bryon R McKay; Michael De Lisio; Jonathon P Little; Mark A Tarnopolsky; Gianni Parise
Journal:  PLoS One       Date:  2011-03-09       Impact factor: 3.240

10.  The interleukin-6-174 G/C promoter polymorphism and arterial stiffness; the Rotterdam Study.

Authors:  Mark P S Sie; Francesco U S Mattace-Raso; André G Uitterlinden; Pascal P Arp; Albert Hofman; Huibert A P Pols; Arnold P G Hoeks; Robert S Reneman; Roland Asmar; Cornelia M van Duijn; Jacqueline C M Witteman
Journal:  Vasc Health Risk Manag       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.